Duke Health: Study Shows MRNA Vaccine Technology Can Be Used for HIV Vaccines
March 16, 2022
March 16, 2022
DURHAM, North Carolina, March 16 (TNSRes) -- Duke Health issued the following news release:
Using mRNA technology like that in the COVID-19 vaccines, researchers have demonstrated a successful way to deliver a potential HIV vaccine, researchers at Duke Human Vaccine Institute report.
Publishing online March 15 in the journal Cell Reports, the research team describes an important advancement in what is a complex vaccine development process. The approach uses mRNAs within . . .
Using mRNA technology like that in the COVID-19 vaccines, researchers have demonstrated a successful way to deliver a potential HIV vaccine, researchers at Duke Human Vaccine Institute report.
Publishing online March 15 in the journal Cell Reports, the research team describes an important advancement in what is a complex vaccine development process. The approach uses mRNAs within . . .